RxDoctor Payments Data

Madison Webb, PA

Physician Assistant · Gallatin, TNNPI 1346779394

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (59.1%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Johnson & Johnson accounts for 60.4% of it on its own, with 28 other manufacturers making up the rest. 2025 is the largest year on record at $31,988, more than ten times the $1,282 reported in 2021. Among physician assistant clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$64,134in general payments, 2019–2025

Across 515 payments — averaging $124.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$39K
  • Sanofi$9K
  • Regeneron Healthcare Solutions, Inc.$5K
  • E.r. Squibb & Sons, L.L.C.$2K
  • AbbVie$2K
  • Takeda Pharmaceuticals U.S.A., Inc.$1K
  • plus $6K from 23 others

What the payments were for

  • Consulting fees$9,11714%
  • Speaking & faculty fees$37,90459%
  • Travel & lodging$4,9318%
  • Food & beverage$11,72518%
  • Education$4571%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$64,134 in reported general payments places this provider in the 95th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$54,782
Medicare patients
373
Services billed
1,090

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa16$330,742
Dupixent PenDupilumab12$43,911
Dupixent SyringeDupilumab11$41,875
Ketoconazole103$1,760
Clobetasol Propionate38$1,705
Betamethasone Dipropionate37$1,420
Doxycycline Hyclate49$1,392
Fluorouracil15$1,307
Imiquimod13$621
Triamcinolone Acetonide43$509
ValacyclovirValacyclovir Hcl17$474
Clindamycin Phosphate11$443
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip19$412
Finasteride12$115
Mupirocin11$95

Paid to pharmacies, not to this prescriber.

Other physician assistant in Gallatin

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →